Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C

Human Immunology

Volumn 69, Issue 12, 2008, Pages 861-866

  Wiederholt, Tonio ^a   von Westernhagen, Michael ^a   Zaldivar, Mirko Moreno ^a   Berres, Marie Luise ^a   Schmitz, Petra ^a   Hellerbrand, Claus ^b   Müller, Tobias ^c   Berg, Thomas ^c   Trautwein, Christian ^a   Wasmuth, Hermann E ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemokine scavenging; Chemokines; D6; Hepatitis C; Liver inflammation

Indexed keywords

CHEMOKINE; MESSENGER RNA; SCAVENGER RECEPTOR D; SCAVENGER RECEPTOR D6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEPATITIS; HEPATITIS C; HISTOLOGY; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BIOLOGICAL MARKERS; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS D;

EID: 57149134256     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.08.275     Document Type: Article

References (41)

1. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
2. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
3. Hamilton T.A., Novotny M., Datta S., Mandal P., Hartupee J., Tebo J., et al. Chemokine and chemoattractant receptor expression: post-transcriptional regulation. J Leukocyte Biol 82 (2007) 213-219
4. Luster A.D., Alon R., and von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 6 (2005) 1182-1190
5. Mantovani A., Locati M., Vecchi A., Sozzani S., and Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 22 (2001) 328-336
6. Mantovani A., Bonecchi R., and Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6 (2006) 907-918
7. Nibbs R.J., Wylie S.M., Yang J., Landau N.R., and Graham G.J. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem 272 (1997) 32078-32083
8. Locati M., Torre Y.M., Galliera E., Bonecchi R., Bodduluri H., Vago G., et al. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth Factor Rev 16 (2005) 679-686
9. Graham G.J., and McKimmie C.S. Chemokine scavenging by D6: a movable feast?. Trends Immunol 27 (2006) 381-386
10. Comerford I., and Nibbs R.J. Post-translational control of chemokines: a role for decoy receptors?. Immunol Lett 96 (2005) 163-174
11. McKimmie C.S., and Graham G.J. Leucocyte expression of the chemokine scavenger D6. Biochem Soc Trans 34 (2006) 1002-1004
12. Weber M., Blair E., Simpson C.V., O'Hara M., Blackburn P.E., Rot A., et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 15 (2004) 2492-2508
13. Bonecchi R., Borroni E.M., Anselmo A., Doni A., Savino B., Mirolo M., et al. Regulation of D6 chemokine scavenging activity by ligand and Rab11-dependent surface upregulation. Blood 112 3 (2008) 493-503
14. Maho A., Bensimon A., Vassart G., and Parmentier M. Mapping of the CCXCR1, CX3CR1, CCBP2 and CCR9 genes to the CCR cluster within the 3p21.3 region of the human genome. Cytogenet Cell Genet 87 (1999) 265-268
15. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
16. Yano M., Kumada H., Kage M., Ikeda K., Shimamatsu K., Inoue O., et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 23 (1996) 1334-1340
17. Zeremski M., Petrovic L.M., and Talal A.H. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepatol 14 (2007) 675-687
18. Wald O., Weiss I.D., Galun E., and Peled A. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics. Cytokine 39 (2007) 50-62
19. Brunt E.M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31 (2000) 241-246
20. Goldin R.D., Goldin J.G., Burt A.D., Dhillon P.A., Hubscher S., Wyatt J., et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 25 (1996) 649-654
21. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
22. Tregouet D.A., and Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 23 (2007) 1038-1039
23. Wasmuth H.E., Zaldivar M.M., Berres M.L., Werth A., Scholten D., Hillebrandt S., et al. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. J Hepatol 48 (2008) 208-215
24. Hellemans J., Mortier G., De Paepe A., Speleman F., and Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8 (2007) R19
25. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) RESEARCH0034
26. Wasmuth H.E., Matern S., and Lammert F. From genotypes to haplotypes in hepatobiliary diseases: one plus one equals (sometimes) more than two. Hepatology 39 (2004) 604-607
27. Hellerbrand C., and Wasmuth H.E. Genomewide genetic association studies in hepatology: the end of searching for the needle in the haystack?. Hepatology 46 (2007) 1661-1663
28. Nischalke H.D., Nattermann J., Fischer H.P., Sauerbruch T., Spengler U., and Dumoulin F.L. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C. Mediators Inflamm 13 (2004) 357-359
29. Apolinario A., Majano P.L., Alvarez-Perez E., Saez A., Lozano C., Vargas J., et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 97 (2002) 2861-2870
30. Goulding C., McManus R., Murphy A., MacDonald G., Barrett S., Crowe J., et al. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut 54 (2005) 1157-1161
31. Wasmuth H.E., Werth A., Mueller T., Berg T., Dietrich C.G., Geier A., et al. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. J Mol Med 82 (2004) 64-69
32. Hellier S., Frodsham A.J., Hennig B.J., Klenerman P., Knapp S., Ramaley P., et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 38 (2003) 1468-1476
33. Promrat K., McDermott D.H., Gonzalez C.M., Kleiner D.E., Koziol D.E., Lessie M., et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124 (2003) 352-360
34. Muhlbauer M., Bosserhoff A.K., Hartmann A., Thasler W.E., Weiss T.S., Herfarth H., et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125 (2003) 1085-1093
35. Moriuchi H., Moriuchi M., and Fauci A.S. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 158 (1997) 3483-3491
36. Bielinski S.J., Pankow J.S., Miller M.B., Hopkins P.N., Eckfeldt J.H., Hixson J., et al. Circulating MCP-1 levels shows linkage to chemokine receptor gene cluster on chromosome 3: the NHLBI Family Heart Study follow-up examination. Genes Immun 8 (2007) 684-690
37. Weber C., and Koenen R.R. Fine-tuning leukocyte responses: towards a chemokine "interactome.". Trends Immunol 27 (2006) 268-273
38. Mattick J.S., and Makunin I.V. Non-coding RNA. Hum Mol Genet 15 Spec No. 1 (2006) R17-R29
39. Jamieson T., Cook D.N., Nibbs R.J., Rot A., Nixon C., McLean P., et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 6 (2005) 403-411
40. Martinez de la Torre Y., Buracchi C., Borroni E.M., Dupor J., Bonecchi R., Nebuloni M., et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 104 (2007) 2319-2324
41. Nibbs R.J., Gilchrist D.S., King V., Ferra A., Forrow S., Hunter K.D., et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 117 (2007) 1884-1892